{"title":"该药可减缓前列腺癌的进展,提高生存率。杜克大学的一项研究是最近发表的三项研究之一,这些研究反映了对抗这种影响数百万男性的疾病的进展。","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":87434,"journal":{"name":"DukeMedicine healthnews","volume":"20 2","pages":"7"},"PeriodicalIF":0.0000,"publicationDate":"2014-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Drug may slow progression and increase prostate cancer survival. A Duke study is one of three recently published investigations that reflect progress against the disease that affects millions of men.\",\"authors\":\"\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":87434,\"journal\":{\"name\":\"DukeMedicine healthnews\",\"volume\":\"20 2\",\"pages\":\"7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"DukeMedicine healthnews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"DukeMedicine healthnews","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Drug may slow progression and increase prostate cancer survival. A Duke study is one of three recently published investigations that reflect progress against the disease that affects millions of men.